-
-
Login
Teplizumab becomes the first NHS-approved treatment shown to delay the onset of type 1 diabetes. Given as a 14-day course of infusions before symptoms develop, the drug could postpone diagnosis by around two to three years and may signal the beginning of a new era in type 1 diabetes treatment.
